Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial
暂无分享，去创建一个
D. Hose | H. Goldschmidt | A. Jauch | T. Hielscher | P. Brossart | M. Merz | C. Kunz | A. Seckinger | C. Scheid | M. Munder | C. Gerecke | U. Bertsch | J. Hillengass | H. Salwender | M. Raab | E. Mai | K. Weisel | M. Haenel | I. Blau | H. Lindemann | M. Zeis | B. Schurich | J. Duerig